Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|17|4|376-385

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.17, Iss.4, 2017-04, pp. : 376-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PI3K/Akt/mTOR Intracellular Pathway and Breast Cancer: Factors, Mechanism and Regulation

By  

Current Pharmaceutical Design, Vol. 23, Iss. 11, 2017-05 ,pp. : 1633-1638

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3K-AKt-mTOR Pathway and New Tools to Prevent Acquired Hormone Resistance in Breast Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 9, 2015-01 ,pp. : 804-815

Bentham Science Publishers

Access to resources Recommend Favorite

Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells

By Cheng Te-Chih   Din Zhong-Hao   Su Jui-Hsin   Wu Yu-Jen   Liu Chih-I  

Marine Drugs, Vol. 15, Iss. 8, 2017-08 ,pp. : 238-238

MDPI

Access to resources Recommend Favorite

Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer

By  

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3070-3080

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 36-62

Bentham Science Publishers

Access to resources Recommend Favorite